UK's MHRA releases report on better regulation of over-the-counter drugs

4 June 2006

Under new rules announced in the UK, makers of non-prescription medicines will be permitted to "self-certify" changes to the labeling of their products, as a first step by the Medicines and Healthcare products Regulatory Agency (MHRA) to make regulation more proportionate and targeted. In this respect, Health Minister Andy Burnham has unveiled the publication of Better Regulation of Over-the-Counter Medicines Initiative (BROMI), which contains the group's first recommendations to reduce the red tape surrounding OTC drugs.

To take this initiative forward the Agency says that it will lead BROMI - a strategy group, which includes representatives from the Proprietary Association of Great Britain, the non-prescription trade body, the National Pharmacy Association and wider government.

The group is considering a range of options for easing unnecessary regulation of OTC medicines and the report, full details of which can be viewed at: www.mhra.gov.uk, sets out recommendations and priorities for action.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight